Dipentum

Product NDC
0037-6860
11-digit product format
000376860
Labeler code
0037
Product ID
0037-6860_9a4c3abc-74c9-4a2c-a8e3-fc0100d873d9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
olsalazine sodium
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Labeler
Viatris Specialty LLC
Application
NDA019715
Marketing category
NDA
Marketing start
2015-05-15
Substance
OLSALAZINE SODIUM
Active strength
250 mg/1
Pharmacologic classes
Aminosalicylate [EPC], Aminosalicylic Acids [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N019715-001DIPENTUMOLSALAZINE SODIUM250MGCAPSULE / ORALRLD, RS1990-07-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-3131067a03dcf5…
2025-08-23 18:47 UTC2025-08N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-316a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-3103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-312680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-315bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-3179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-311e350fbaab3a…
2024-05-31 18:47 UTC2024-05N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-318072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-3187673890dc5c…
2021-03-12 10:30 UTC2021-03N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-315aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-318869cabd3fbd…
2020-11-12 02:37 UTC2020-11N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31c0c555d07b60…
2019-12-14 00:12 UTC2019-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-313f01610625f2…
2019-09-15 20:21 UTC2019-09N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31b00525d2431f…
2019-07-19 19:46 UTC2019-07N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-316a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-311c564ffb4f44…
2023-12-20 04:57 UTC2023-12N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-319b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-313f0d92c62455…
2023-05-13 08:27 UTC2023-05N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31053a50430f4f…
2023-01-26 05:58 UTC2023-01N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-313bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-313a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N019715-001DIPENTUM250MGCAPSULE / ORALRLD, RS1990-07-31cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Dipentum
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OLSALAZINE SODIUM250 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
Y7JEW0XG7IInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
905162Internal RxNorm lookup
905164Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8512d0c6-db4e-4673-b3b4-28975c18413fAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6caced09-10d9-0a78-cc7d-35b444e1642bProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0037-6860-10Dipentum100 in 1 BOTTLE, PLASTICCAPSULE, GELATIN COATED10015

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0037-6860-10EA - Each0037-686015c44237-9463-40ed-af62-9799cdc80f7712015-06-09

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0037-6860DIPENTUM (OLSALAZINE SODIUM) CAPSULE, GELATIN COATED [MEDA PHARMACEUTICALS INC.]14Current NDC, Legacy NDC, 1 package rows20240830_8512d0c6-db4e-4673-b3b4-28975c18413f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DipentumOLSALAZINE SODIUMViatris Specialty LLC8512d0c6-db4e-4673-b3b4-28975c18413f2024-07-18Warnings, Adverse reactionsExact identifier
application applno (NDA): 019715
application number: NDA019715
ndc (product): 0037-6860

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
905164Dipentum 250 MG Oral CapsulePSN8512d0c6-db4e-4673-b3b4-28975c18413f15
905162olsalazine sodium 250 MG Oral CapsulePSN8512d0c6-db4e-4673-b3b4-28975c18413f15
905164olsalazine sodium 250 MG Oral Capsule [Dipentum]SBD8512d0c6-db4e-4673-b3b4-28975c18413f15
905162olsalazine sodium 250 MG Oral CapsuleSCD8512d0c6-db4e-4673-b3b4-28975c18413f15
905164Dipentum 250 MG Oral CapsuleSY8512d0c6-db4e-4673-b3b4-28975c18413f15
905164Dipentum 250 MG Oral CapsulePSN9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905162olsalazine sodium 250 MG Oral CapsulePSN9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905164olsalazine sodium 250 MG Oral Capsule [Dipentum]SBD9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905162olsalazine sodium 250 MG Oral CapsuleSCD9dd522a3-587e-44ab-9de3-a0fd079f2ffb3
905164Dipentum 250 MG Oral CapsuleSY9dd522a3-587e-44ab-9de3-a0fd079f2ffb3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0037-6860-1000037686010100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0037-6860-10) 2015-05-150000-00-00NoNoCurrent